A multicenter, randomized controlled trial of immediate total-body CT scanning in trauma patients (REACT-2).

ABSTRACT:

Background

Computed tomography (CT) scanning has become essential in the early diagnostic phase of trauma care because of its high diagnostic accuracy. The introduction of multi-slice CT scanners and infrastructural improvements made total-body CT scanning technically feasible and its usage is currently becoming common practice in several trauma centers. However, literature provides limited evidence whether immediate total-body CT leads to better clinical outcome then conventional radiographic imaging supplemented with selective CT scanning in trauma patients. The aim of the REACT-2 trial is to determine the value of immediate total-body CT scanning in trauma patients.

Methods/design

The REACT-2 trial is an international, multicenter randomized clinical trial. All participat

SUBMITTER: Sierink JC 

PROVIDER: S-EPMC3361475 | biostudies-literature | 2012 Mar

REPOSITORIES: biostudies-literature